Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	SNARE binding	VPS11 RAB11A GOLGA6D DAPK1 GOLGA6B GRIK2 GOLGA6A SEC24D STXBP1	1.53e-06	136	160	9	GO:0000149
GeneOntologyMolecularFunction	syntaxin binding	VPS11 RAB11A GOLGA6D DAPK1 GOLGA6B GOLGA6A STXBP1	6.35e-06	87	160	7	GO:0019905
GeneOntologyMolecularFunction	importin-alpha family protein binding	RB1 GOLGA6D GOLGA6B GOLGA6A	2.14e-05	21	160	4	GO:0061676
GeneOntologyMolecularFunction	nuclear export signal receptor activity	RANBP17 CSE1L EIF4ENIF1	1.05e-04	12	160	3	GO:0005049
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	HDAC9 KDM3A NCOA6 RB1 SETD6 SRF HIPK2 CREB1 DUSP26 GTF2A1 TAF4 SPEN	1.40e-04	417	160	12	GO:0061629
GeneOntologyMolecularFunction	1-phosphatidylinositol-5-phosphate 4-kinase activity	PIP4K2B PIP4K2C	1.90e-04	3	160	2	GO:0016309
GeneOntologyMolecularFunction	translation regulator activity, nucleic acid binding	EIF2S3B PABPC1 EIF3CL EEF1D EEF2 EIF2S3	2.86e-04	112	160	6	GO:0090079
GeneOntologyMolecularFunction	translation factor activity, RNA binding	EIF2S3B EIF3CL EEF1D EEF2 EIF2S3	6.07e-04	85	160	5	GO:0008135
GeneOntologyMolecularFunction	histone H3K9me/H3K9me2 demethylase activity	KDM3A KDM3B	6.28e-04	5	160	2	GO:0140683
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	HDAC9 KDM3A NCOA6 RB1 SETD6 SRF HIPK2 CREB1 DUSP26 GTF2A1 EEF1D TAF4 SPEN	8.44e-04	582	160	13	GO:0140297
GeneOntologyBiologicalProcess	regulation of DNA-templated transcription initiation	MORC1 DHX36 MED9 SRF CREB1 GTF2A1 TAF4	7.24e-06	91	161	7	GO:2000142
GeneOntologyBiologicalProcess	positive regulation of transcription initiation by RNA polymerase II	DHX36 MED9 SRF CREB1 GTF2A1 TAF4	1.79e-05	70	161	6	GO:0060261
GeneOntologyBiologicalProcess	positive regulation of DNA-templated transcription initiation	DHX36 MED9 SRF CREB1 GTF2A1 TAF4	3.09e-05	77	161	6	GO:2000144
GeneOntologyBiologicalProcess	regulation of transcription initiation by RNA polymerase II	DHX36 MED9 SRF CREB1 GTF2A1 TAF4	4.12e-05	81	161	6	GO:0060260
GeneOntologyBiologicalProcess	organelle inheritance	GOLGA6D GOLGA6B GOLGA6A VPS13B	6.33e-05	28	161	4	GO:0048308
GeneOntologyBiologicalProcess	Golgi inheritance	GOLGA6D GOLGA6B GOLGA6A VPS13B	6.33e-05	28	161	4	GO:0048313
GeneOntologyBiologicalProcess	DNA-templated transcription initiation	MORC1 DHX36 NCOA6 MED9 SRF CREB1 GTF2A1 GTF3C1 TAF4	8.67e-05	231	161	9	GO:0006352
GeneOntologyBiologicalProcess	intracellular transport	VPS11 MAGEL2 RBM33 AHCTF1 RAB11A GOLGA6D SLU7 GOLGA6B GOLGA6A AXIN1 RANBP17 ERGIC1 SEC24D CSE1L NF1 STXBP1 EIF4ENIF1 NUP155 AP2B1 ATXN1 GLE1 CSPG5 SEC23IP TRAPPC10 C9orf72 VPS13B	9.57e-05	1496	161	26	GO:0046907
GeneOntologyBiologicalProcess	neuron projection development	DHX36 ROBO4 RB1 ROR1 NCKIPSD RAB11A ADGRB1 GOLGA6D SRF CHAT GOLGA6B GOLGA6A CREB1 NF1 STXBP1 HMCN2 CELSR3 CSPG5 PCDH15 CTNND2 C9orf72 VPS13B EPHB1	1.65e-04	1285	161	23	GO:0031175
GeneOntologyBiologicalProcess	neuron development	DHX36 ROBO4 RB1 ROR1 NCKIPSD RAB11A ADGRB1 GOLGA6D SRF CHAT GOLGA6B GOLGA6A CREB1 OPCML NF1 STXBP1 HMCN2 CELSR3 CSPG5 PCDH15 RP1 CTNND2 C9orf72 VPS13B EPHB1	1.72e-04	1463	161	25	GO:0048666
GeneOntologyBiologicalProcess	1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process	PIP4K2B PIP4K2C	1.81e-04	3	161	2	GO:1902635
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	FOXM1 DMTF1 DHX36 KDM3A NCOA6 DDX17 RB1 MED9 SRF HIPK2 ITGA8 MLLT10 CREB1 CREB5 GTF2A1 EEF1D ATXN1 MED12L ZFHX3 TAF4 NFAT5 IL4I1 ZFP62 MIR9-1HG	2.02e-04	1390	161	24	GO:0045944
MousePheno	abnormal actin cytoskeleton morphology	NCKIPSD GOLGA6D GOLGA6B GOLGA6A VPS13B	1.73e-05	34	135	5	MP:0020849
Pathway	WP_TRANSLATION_FACTORS	EIF2S3B PABPC1 EIF3CL EEF1D EEF2 EIF2S3	4.21e-06	51	119	6	MM15881
Pathway	BIOCARTA_EIF_PATHWAY	EIF2S3B EEF2 EIF2S3	6.74e-05	10	119	3	MM1394
Pathway	REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT	GOLGA6D GOLGA6B GOLGA6A SEC24D SEC23IP TRAPPC10	7.09e-05	83	119	6	MM14819
Pubmed	Human transcription factor protein interaction networks.	DHX36 NCOA6 DNAH10 RB1 RBM33 HIPK2 SLU7 MLLT10 SRCAP ZHX2 ANKHD1 CREB1 PABPC1 EEF1D CSE1L EIF4ENIF1 GTF3C1 ZFHX4 ATXN1 ZNF592 YLPM1 ZNF638 ZFHX3 QSER1 TAF4 SPEN GARRE1 FOXK1	1.02e-10	1429	161	28	35140242
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	DDX17 RB1 MCM3 CREB1 ZBTB24 CREB5 EEF2 NUP155 GTF3C1 ZFHX4 ATXN1 ZNF592 ZFHX3 TAF4 NFAT5 FOXK1	1.52e-08	583	161	16	29844126
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	DDX17 AHCTF1 MCM3 PABPC1 KIF20A EEF1D EEF2 ZNF592 EIF2S3 DDX23 PIP4K2B TAF4 PIP4K2C FOXK1	2.10e-08	441	161	14	31239290
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	PKP4 GOLGA6D ARHGEF12 MCM3 DAPK1 GOLGA6B GRIK2 GOLGA6A PABPC1 EEF2 NF1 AP2B1 YLPM1 SEC23IP MIOS QSER1 TAF4 PIP4K2C CTNND2 SPATA13	2.40e-08	963	161	20	28671696
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	DOCK1 DHX36 DDX17 PKP4 SRR PABPC1 ERGIC1 C2CD3 GTF3C1 AP2B1 GLE1 YLPM1 ZNF638 TMEM131	3.74e-08	462	161	14	31138677
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	RBM33 AHCTF1 ROR1 AXIN1 GTF2A1 EIF4ENIF1 NUP155 SEC23IP ZNF638 TMEM131 VPS13B	4.60e-08	263	161	11	34702444
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	DHX36 NCOA6 KDM3B SRCAP GTF3C1 SBNO1 YLPM1 ZNF638 DDX23 SPEN FOXK1 AQR	7.34e-08	341	161	12	32971831
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DHX36 DDX17 RB1 AHCTF1 PKP4 SLU7 MCM3 SRCAP ANKHD1 PABPC1 KIF20A EEF1D EEF2 CSE1L NF1 NUP155 GTF3C1 AP2B1 PLEKHG3 ZNF638 DDX23 PIP4K2C AQR	7.71e-08	1353	161	23	29467282
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	DDX17 RAB11A GOLGA6D GOLGA6B GOLGA6A SRCAP PABPC1 EEF1D EEF2 C2CD3 STXBP1 GTF3C1 AP2B1 SBNO1 YLPM1 SEC23IP PKHD1 DDX23 PIP4K2B TAF4 SPEN SPATA13 UTP14C	2.38e-07	1442	161	23	35575683
Pubmed	Characterization of the piRNA complex from rat testes.	KDM3A RBM33 GOLGA6D GOLGA6B GOLGA6A GTF2A1 SBNO1 NFAT5	3.15e-07	140	161	8	16778019
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	DHX36 ROBO4 FRAS1 DDX17 MCM3 PABPC1 EEF1D EEF2 CSE1L AP2B1 SBNO1 YLPM1 NADK DDX23 FOXK1	4.29e-07	653	161	15	33742100
Pubmed	Tagging genes with cassette-exchange sites.	KDM5B DDX17 ARHGEF12 EIF3CL RANBP17 CSE1L SBNO1 PIP4K2B TMEM131 TAF4 AQR	5.18e-07	335	161	11	15741177
Pubmed	Synchronized mesenchymal cell polarization and differentiation shape the formation of the murine trachea and esophagus.	ROR1 GOLGA6D SRF GOLGA6B GOLGA6A	6.71e-07	36	161	5	30026494
Pubmed	p125/Sec23-interacting protein (Sec23ip) is required for spermiogenesis.	GOLGA6D GOLGA6B GOLGA6A SEC23IP	7.71e-07	16	161	4	21640725
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	DHX36 DDX17 PKP4 NCKIPSD ARHGEF12 DAPK1 EIF2S3B PABPC1 OPCML EIF3CL GJA3 EEF1D EEF2 CSE1L NF1 STXBP1 AP2B1 EIF2S3 MIOS TRAPPC10 PIP4K2C CTNND2	8.26e-07	1431	161	22	37142655
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	FRAS1 DDX17 AHCTF1 ADGRB1 MCM3 ABHD4 DUSP26 EEF1D EEF2 CELSR3 EIF2S3 DSG4 ALPK2	8.83e-07	513	161	13	25798074
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	NCOA6 DDX17 RBM33 AHCTF1 SLU7 GTF2A1 YLPM1 ZNF638 ZFHX3 SPEN	8.95e-07	283	161	10	30585729
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	KDM3A RB1 AHCTF1 KDM3B SRCAP ZBTB24 KIF20A GTF3C1 SBNO1 ZNF592 QSER1 TAF4 SPEN FOXK1	1.03e-06	608	161	14	36089195
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	ARHGEF12 NF1 HMCN2 CELSR3 ZFHX4 ZNF592 MAPKAPK3 NADK PIP4K2B CTNND2 SPEN	1.08e-06	361	161	11	26167880
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	FOXM1 DMTF1 KDM5B AHCTF1 SRF KDM3B MLLT10 SRCAP ZBTB24 GTF2A1 ATXN1 ZNF592 ZNF638 ZFHX3 NFAT5 FOXK1	1.23e-06	808	161	16	20412781
Pubmed	Deletion of IFT20 exclusively in the RPE ablates primary cilia and leads to retinal degeneration.	GATD3 GOLGA6D GOLGA6B GOLGA6A	1.62e-06	19	161	4	38048369
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	DHX36 DDX17 AHCTF1 PKP4 BTBD10 SLU7 MCM3 PABPC1 EIF3CL EEF1D EEF2 CSE1L NUP155 GTF3C1 AP2B1 PLEKHG3 EIF2S3 ZNF638 SPEN AQR	1.63e-06	1257	161	20	36526897
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	NCOA6 RBM33 AHCTF1 ANKHD1 EIF4ENIF1 NUP155 GLE1 YLPM1 SEC23IP ZNF638 QSER1 FOXK1	1.64e-06	457	161	12	32344865
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	KDM3A NCOA6 AHCTF1 KDM3B MCM3 SRCAP ANKHD1 GTF3C1 YLPM1 SEC23IP QSER1 TAF4 SPEN	1.87e-06	549	161	13	38280479
Pubmed	Intraflagellar transport molecules in ciliary and nonciliary cells of the retina.	GOLGA6D GOLGA6B GOLGA6A RP1	2.02e-06	20	161	4	20368623
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	DHX36 FRAS1 PKP4 KDM3B ANKHD1 FHIP2A SLC4A2 NUP155 GTF3C1 EIF2S3 ZNF638 QSER1 GARRE1 AQR	2.24e-06	650	161	14	38777146
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	NCOA6 DDX17 RBM33 AHCTF1 SLU7 MCM3 EIF2S3B CREB1 PABPC1 EEF1D EEF2 EIF2S3 YLPM1 ZNF638 QSER1 TAF4 SPEN	2.34e-06	954	161	17	36373674
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	DHX36 AHCTF1 ANKHD1 PABPC1 CSE1L NF1 NUP155 GTF3C1 AP2B1 YLPM1 ZNF638 DDX23 SPEN AQR	2.36e-06	653	161	14	22586326
Pubmed	Rap2 function requires palmitoylation and recycling endosome localization.	RAB11A GOLGA6D GOLGA6B GOLGA6A	2.49e-06	21	161	4	19061864
Pubmed	Over-expression of Rififylin, a new RING finger and FYVE-like domain-containing protein, inhibits recycling from the endocytic recycling compartment.	RAB11A GOLGA6D GOLGA6B GOLGA6A	2.49e-06	21	161	4	15229288
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	DMTF1 ZNF821 AHCTF1 HIPK2 SLU7 SRCAP ANKHD1 ZBTB24 PTPRR ZNF638 NADK TRAPPC10 TMEM131 ANKRD12 QSER1 NFAT5 VPS13B UTP14C	3.11e-06	1084	161	18	11544199
Pubmed	Reelin and stk25 have opposing roles in neuronal polarization and dendritic Golgi deployment.	GOLGA6D GOLGA6B GOLGA6A RLN2	3.66e-06	23	161	4	21111240
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	KDM3A NCOA6 DDX17 RBM33 KDM3B SLU7 CREB1 PABPC1 EEF1D EEF2 GTF3C1 AP2B1 EIF2S3 DDX23 QSER1 TAF4 SPEN FOXK1	3.96e-06	1103	161	18	34189442
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	FOXM1 KDM3A RB1 KDM3B SLU7 GTF2A1 CSE1L GTF3C1 SBNO1 SPEN	4.48e-06	339	161	10	30415952
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	KDM3A DDX17 RBM33 AHCTF1 KDM3B SRCAP PABPC1 EEF2 YLPM1 DDX23 TTC17 AQR	4.64e-06	506	161	12	30890647
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ATP7B RB1 AHCTF1 PKP4 SRCAP ANKHD1 KIF20A HMCN2 EIF4ENIF1 ZFHX4 ATXN1 ZNF592 PIP4K2B ZFHX3 TAF4 PIP4K2C GARRE1 FOXK1	4.65e-06	1116	161	18	31753913
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DOCK1 SRF HIPK2 GRIK2 ZHX2 RANBP17 ERGIC1 GTF3C1 ATXN1 PTPRR PLEKHG3 PVR ZNF638 ZFHX3 TTC17 ANKRD12 QSER1 TAF4 NFAT5 SH3RF3 VPS13B	5.74e-06	1489	161	21	28611215
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	DOCK1 DMTF1 NCOA6 MAGEL2 MLLT10 PABPC1 EIF4ENIF1 NUP155 AP2B1 YLPM1 SPEN	5.76e-06	430	161	11	35044719
Pubmed	Interaction network of human early embryonic transcription factors.	NCOA6 ZHX2 ZFHX4 ATXN1 ZFHX3 QSER1 TAF4 SPEN PRDM6 FOXK1	6.08e-06	351	161	10	38297188
Pubmed	Wnt11 directs nephron progenitor polarity and motile behavior ultimately determining nephron endowment.	GOLGA6D ITGA8 GOLGA6B GOLGA6A	7.14e-06	27	161	4	30516471
Pubmed	Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.	NCOA6 AHCTF1 SLU7 RANBP17 STXBP1 HMCN2 DDX23 SPEN AQR	7.48e-06	283	161	9	18854154
Pubmed	The Y172 Monoclonal Antibody Against p-c-Jun (Ser63) Is a Marker of the Postsynaptic Compartment of C-Type Cholinergic Afferent Synapses on Motoneurons.	GOLGA6D CHAT GOLGA6B GOLGA6A	8.31e-06	28	161	4	32038174
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	HDAC9 KDM3A ZNF821 KDM5B GATD3 CFAP91 LRP1B ZNF251 EEF2 STXBP1 CELSR3 AP2B1 SBNO1 ZNF592 YLPM1 SEC23IP TTC17 TMEM131 CTNND2	8.58e-06	1285	161	19	35914814
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ATP7B RBM33 KDM3B SLC4A2 EIF4ENIF1 GLE1 YLPM1 SEC23IP ZNF638 MIOS PIP4K2B TTC17 TMEM131 QSER1	8.80e-06	733	161	14	34672954
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	DDX17 MCM3 ZNF251 PABPC1 EEF2 CSE1L AP2B1 SEC23IP MIOS FOXK1 ZFP62	9.00e-06	451	161	11	36168627
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	HDAC9 KDM3A KDM5B NCOA6 SETD6 KDM3B SRCAP	9.10e-06	157	161	7	30186101
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	DDX17 KDM3B HIPK2 MCM3 CSE1L YLPM1 DDX23 ZFHX3	9.24e-06	220	161	8	35785414
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	DDX17 RBM33 RAB11A MCM3 PABPC1 EEF1D EEF2 CSE1L NUP155 AP2B1 EIF2S3 SEC23IP FOXK1	9.44e-06	638	161	13	33239621
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ROBO4 NCOA6 RAB11A KDM3B MUC16 SLU7 ZNF251 NF1 STXBP1 SEC23IP DSG4 CTNND2 SPEN	9.44e-06	638	161	13	31182584
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	DHX36 AHCTF1 SLU7 MLLT10 CSE1L NUP155 GTF3C1 AP2B1 ZNF638 UTP14C	9.62e-06	370	161	10	22922362
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	FOXM1 GATD3 RB1 MED9 SRCAP ZBTB24 KIF20A C2CD3 ZNF592 ZNF638 PIP4K2B PIP4K2C SPEN	1.06e-05	645	161	13	25281560
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	KDM5B NCOA6 NCKIPSD KDM3B PABPC1 C2CD3 NF1 ATXN1 PLEKHG3 NADK SH3RF3 GARRE1 FOXK1 AQR SPATA13	1.24e-05	861	161	15	36931259
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	DHX36 DDX17 ANKHD1 PABPC1 EEF1D EEF2 CSE1L EIF4ENIF1 GTF3C1 YLPM1 DDX23 TAF4 ZFP62	1.25e-05	655	161	13	35819319
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	CFAP91 DDX17 RB1 MCM3 EIF3CL ERGIC1 CSE1L NF1 EIF4ENIF1 AP2B1 SBNO1 SEC23IP ZNF638 NADK MIOS TRAPPC10 QSER1 SH3RF3 FOXK1	1.26e-05	1321	161	19	27173435
Pubmed	Rab11 is essential to pancreas morphogenesis, lumen formation and endocrine mass.	RAB11A GOLGA6D GOLGA6B GOLGA6A	1.44e-05	32	161	4	37172642
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	FOXM1 KDM3A NCOA6 KDM3B MCM3 EIF3CL EEF2 NF1 GTF3C1 ZNF592 YLPM1 ZNF638 TRAPPC10 SPEN	1.61e-05	774	161	14	15302935
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	DDX17 RAB11A KDM3B MUC16 MCM3 KIF20A SEC24D EEF2 NUP155 EIF2S3 SEC23IP ZNF638 ZFHX3 SPEN	1.68e-05	777	161	14	35844135
Pubmed	AMPK, a Regulator of Metabolism and Autophagy, Is Activated by Lysosomal Damage via a Novel Galectin-Directed Ubiquitin Signal Transduction System.	DDX17 PABPC1 AXIN1 SLC4A2 SEC24D EEF1D EEF2 NUP155 EIF2S3 PVR SEC23IP	1.73e-05	484	161	11	31995728
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	DDX17 MCM3 PABPC1 KIF20A EEF1D EEF2 CSE1L NUP155 AP2B1 SEC23IP CRBN	2.09e-05	494	161	11	26831064
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	RB1 KDM3B MCM3 EEF1D EEF2 CSE1L NUP155 GTF3C1 SBNO1 ZNF592 YLPM1 DDX23 QSER1 TAF4 FOXK1 AQR	2.11e-05	1014	161	16	32416067
Pubmed	Cloning and characterization of a Golgin-related gene from the large-scale polymorphism linked to the PML gene.	GOLGA6B GOLGA6A	2.13e-05	2	161	2	11161787
Pubmed	Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas.	KDM5B RB1	2.13e-05	2	161	2	15803180
Pubmed	The RNA helicase DHX36-G4R1 modulates C9orf72 GGGGCC hexanucleotide repeat-associated translation.	DHX36 C9orf72	2.13e-05	2	161	2	34174288
Pubmed	FOXM1 regulates radiosensitivity of lung cancer cell partly by upregulating KIF20A.	FOXM1 KIF20A	2.13e-05	2	161	2	29704495
Pubmed	Serine 133-phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neurotrophin signals.	SRF CREB1	2.13e-05	2	161	2	7551568
Pubmed	The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers.	ZFHX4 ZFHX3	2.13e-05	2	161	2	10873665
Pubmed	A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders.	GOLGA6B GOLGA6A	2.13e-05	2	161	2	11509185
Pubmed	Human chromosome 15q11-q14 regions of rearrangements contain clusters of LCR15 duplicons.	GOLGA6B GOLGA6A	2.13e-05	2	161	2	11896453
Pubmed	Expression of ROR1, pAkt, and pCREB in gastric adenocarcinoma.	ROR1 CREB1	2.13e-05	2	161	2	26245996
Pubmed	Identification and localization of a neurally expressed member of the plakoglobin/armadillo multigene family.	PKP4 CTNND2	2.13e-05	2	161	2	9342840
Pubmed	The armadillo protein p0071 is involved in Rab11-dependent recycling.	PKP4 RAB11A	2.13e-05	2	161	2	24163434
Pubmed	Histone deacetylase 9 as a negative regulator for choline acetyltransferase gene in NG108-15 neuronal cells.	HDAC9 CHAT	2.13e-05	2	161	2	22226696
Pubmed	Sec23IP recruits VPS13B/COH1 to ER exit site-Golgi interface for tubular ERGIC formation.	SEC23IP VPS13B	2.13e-05	2	161	2	39352497
Pubmed	Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance.	FOXM1 KIF20A	2.13e-05	2	161	2	25961928
Pubmed	Arsenic-Induced Activation of the Homeodomain-Interacting Protein Kinase 2 (HIPK2) to cAMP-Response Element Binding Protein (CREB) Axis.	HIPK2 CREB1	2.13e-05	2	161	2	27884605
Pubmed	Additional complexity on human chromosome 15q: identification of a set of newly recognized duplicons (LCR15) on 15q11-q13, 15q24, and 15q26.	GOLGA6B GOLGA6A	2.13e-05	2	161	2	11156619
Pubmed	Regulation of genotoxic stress response by homeodomain-interacting protein kinase 2 through phosphorylation of cyclic AMP response element-binding protein at serine 271.	HIPK2 CREB1	2.13e-05	2	161	2	20573984
Pubmed	Neocentromeres in 15q24-26 map to duplicons which flanked an ancestral centromere in 15q25.	GOLGA6B GOLGA6A	2.13e-05	2	161	2	12915487
Pubmed	The histone demethylase Jarid1b (Kdm5b) is a novel component of the Rb pathway and associates with E2f-target genes in MEFs during senescence.	KDM5B RB1	2.13e-05	2	161	2	21980403
Pubmed	Microsatellite abnormalities and somatic down-regulation of mismatch repair characterize nodular-trabecular muscle-invasive urothelial carcinoma of the bladder.	RB1 NF1	2.13e-05	2	161	2	17880527
Pubmed	Sexually dimorphic expression of the X-linked gene Eif2s3x mRNA but not protein in mouse brain.	EIF2S3B EIF2S3	2.13e-05	2	161	2	16325480
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FRAS1 ARHGEF12 ZHX2 FHIP2A ANKRD12 SPEN NFAT5 VPS13B AQR SPATA13	2.18e-05	407	161	10	12693553
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	DDX17 MCM3 SRCAP PABPC1 EEF1D CSE1L NF1 NUP155 GTF3C1 GLE1 PLEKHG3 YLPM1 ZNF638 DDX23 SPEN AQR	2.38e-05	1024	161	16	24711643
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	RBM33 GOLGA6D MCM3 GOLGA6B GOLGA6A PABPC1 EIF3CL EEF1D EEF2 AP2B1 YLPM1 ZNF638 PIP4K2B	2.53e-05	701	161	13	30196744
Pubmed	Globozoospermia and lack of acrosome formation in GM130-deficient mice.	GOLGA6D GOLGA6B GOLGA6A	2.69e-05	13	161	3	28055014
Pubmed	GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells.	GOLGA6D GOLGA6B GOLGA6A	2.69e-05	13	161	3	33740186
Pubmed	Loss of GM130 does not impair oocyte meiosis and embryo development in mice.	GOLGA6D GOLGA6B GOLGA6A	2.69e-05	13	161	3	32873390
Pubmed	GM130, a cis-Golgi protein, regulates meiotic spindle assembly and asymmetric division in mouse oocyte.	GOLGA6D GOLGA6B GOLGA6A	2.69e-05	13	161	3	21552007
Pubmed	Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice.	GOLGA6D GOLGA6B GOLGA6A	2.69e-05	13	161	3	28028212
Pubmed	GOLGA2 loss causes fibrosis with autophagy in the mouse lung and liver.	GOLGA6D GOLGA6B GOLGA6A	2.69e-05	13	161	3	29128360
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	DDX17 SLU7 MCM3 PABPC1 CSE1L ZFHX4 ZNF592 YLPM1 ZNF638 DDX23 ZFHX3 SPEN	2.73e-05	605	161	12	28977666
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	ROBO4 ROR1 PPM1M MUC16 DUSP26 CSE1L NF1 PTPRH PTPRR SPEN	2.85e-05	420	161	10	28065597
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	DHX36 DDX17 RAB11A SLU7 MCM3 ANKHD1 PABPC1 EEF1D EEF2 CSE1L STXBP1 DDX23 AQR	3.06e-05	714	161	13	28302793
Pubmed	Defining the membrane proteome of NK cells.	KDM3A DDX17 ATP7B SLU7 MCM3 PABPC1 SLC4A2 ERGIC1 EEF2 CSE1L NF1 EIF4ENIF1 NUP155 GTF3C1 AP2B1 GLE1 AQR	3.21e-05	1168	161	17	19946888
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	DHX36 DDX17 RAB11A MCM3 EIF2S3B ANKHD1 PABPC1 EEF1D EEF2 CSE1L NUP155 AP2B1 SBNO1 EIF2S3 ZNF638 DDX23 PIP4K2C FOXK1 AQR	3.24e-05	1415	161	19	28515276
Pubmed	KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.	KDM3A RBM33 KDM3B SLU7 SBNO1 ZNF638	3.33e-05	130	161	6	35545047
Pubmed	Cdk1 protects against oxygen-glucose deprivation and reperfusion-induced Golgi fragmentation and apoptosis through mediating GM130 phosphorylation.	GOLGA6D GOLGA6B GOLGA6A	3.41e-05	14	161	3	37831422
Pubmed	GM130 and p115 play a key role in the organisation of the early secretory pathway during skeletal muscle differentiation.	GOLGA6D GOLGA6B GOLGA6A	3.41e-05	14	161	3	30630895
Pubmed	Golgb1 regulates protein glycosylation and is crucial for mammalian palate development.	GOLGA6D GOLGA6B GOLGA6A	3.41e-05	14	161	3	27226319
Pubmed	Oligoasthenoteratospermia and sperm tail bending in PPP4C-deficient mice.	GOLGA6D GOLGA6B GOLGA6A	3.41e-05	14	161	3	33543287
Interaction	NFIX interactions	RB1 SRF SRCAP ZHX2 CREB1 GTF3C1 ZFHX4 ATXN1 ZFHX3 QSER1 TAF4 SPEN	2.59e-07	227	159	12	int:NFIX
Interaction	NUP50 interactions	DHX36 KDM3A RBM33 AHCTF1 KDM3B GTF2A1 CSE1L STXBP1 EIF4ENIF1 NUP155 AP2B1 SBNO1 TAF4 SPEN	5.57e-07	341	159	14	int:NUP50
Interaction	FEV interactions	NCOA6 MLLT10 ZHX2 CREB1 GTF3C1 ZFHX4 ATXN1 ZFHX3 QSER1 TAF4 FOXK1	6.51e-07	203	159	11	int:FEV
Interaction	RNF43 interactions	DHX36 KDM5B DDX17 RBM33 AHCTF1 ROR1 AXIN1 GTF2A1 EIF4ENIF1 NUP155 SEC23IP ZNF638 TMEM131 VPS13B	7.66e-06	427	159	14	int:RNF43
Interaction	TERF2IP interactions	KDM3A NCOA6 RB1 AHCTF1 KDM3B SLU7 SRCAP GTF3C1 AP2B1 SBNO1 ZNF592 ZNF638 DDX23 QSER1 TAF4 SPEN	7.99e-06	552	159	16	int:TERF2IP
Interaction	PAX9 interactions	KDM5B NCOA6 ZHX2 ZFHX4 ATXN1 ZFHX3 QSER1 FOXK1	9.05e-06	130	159	8	int:PAX9
Interaction	PRPF8 interactions	FOXM1 DDX17 RBM33 SLU7 PABPC1 KIF20A DUSP26 EEF1D EEF2 CSE1L NUP155 ATXN1 EIF2S3 DDX23 PIP4K2B PIP4K2C C9orf72 SPEN AQR	1.22e-05	776	159	19	int:PRPF8
Interaction	FHL2 interactions	MAGEL2 SRF HIPK2 SLU7 GOLGA6A CREB1 ATXN1 ZNF638 QSER1 SPEN NFAT5 PRDM6 FOXK1	1.62e-05	396	159	13	int:FHL2
Interaction	PAX6 interactions	NCOA6 GATD3 RB1 HIPK2 SRCAP ZHX2 GTF3C1 ZFHX4 ATXN1 ZFHX3 QSER1 FOXK1	3.50e-05	366	159	12	int:PAX6
Interaction	AR interactions	KDM3A KDM5B NCOA6 DDX17 RB1 RBM33 KDM3B HIPK2 MCM3 SRCAP CREB1 PABPC1 EEF2 CSE1L ATXN1 YLPM1 MED12L DDX23 ZFHX3 QSER1 FOXK1	3.62e-05	992	159	21	int:AR
Interaction	CEBPB interactions	HDAC9 DHX36 DDX17 RB1 AHCTF1 RAB11A SRF KDM3B MCM3 ANKHD1 CREB1 PABPC1 CREB5 GTF2A1 SEC24D EEF1D EEF2 CSE1L AP2B1 EIF2S3 YLPM1 SEC23IP ZNF638 DDX23 NFAT5 FOXK1	6.24e-05	1443	159	26	int:CEBPB
Interaction	GSC interactions	ZFHX4 ATXN1 ZFHX3 DSG4 QSER1 PRDM6	6.54e-05	87	159	6	int:GSC
Interaction	RBMX interactions	FOXM1 DHX36 DDX17 SLU7 MCM3 PABPC1 KIF20A YLPM1 SEC23IP DDX23 PIP4K2C C9orf72 CRBN	7.73e-05	461	159	13	int:RBMX
Interaction	CIC interactions	DDX17 RB1 MCM3 CREB1 ZBTB24 CREB5 EEF2 NUP155 GTF3C1 ZFHX4 ATXN1 ZNF592 ZFHX3 TAF4 NFAT5 FOXK1	8.73e-05	673	159	16	int:CIC
Interaction	CSNK1A1L interactions	ARHGEF12 KIF20A PLEKHG3 PIP4K2B PIP4K2C	9.39e-05	58	159	5	int:CSNK1A1L
Interaction	CTBP1 interactions	HDAC9 RB1 HIPK2 CREB5 EEF1D EIF4ENIF1 ATXN1 SEC23IP ZNF518B C9orf72 SPEN FOXK1	9.45e-05	406	159	12	int:CTBP1
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZHX2 ZFHX4 ZFHX3	8.71e-05	15	107	3	529
GeneFamily	PHD finger proteins\|Lysine demethylases	KDM3A KDM5B KDM3B	3.73e-04	24	107	3	485
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	ROBO4 ROR1 OPCML HMCN2 PXDNL ALPK2	3.91e-04	161	107	6	593
GeneFamily	Nucleoporins	AHCTF1 NUP155 GLE1	8.82e-04	32	107	3	1051
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DOCK1 KDM3A KDM5B DDX17 UBL3 RB1 AHCTF1 PKP4 ROR1 KDM3B DAPK1 ZHX2 CREB1 CREB5 SEC24D C2CD3 CSE1L ATXN1 ZNF638 ZFHX3 TMEM131 TAF4 SPEN GARRE1 VPS13B AQR	1.27e-11	856	159	26	M4500
Coexpression	SHEN_SMARCA2_TARGETS_UP	NCOA6 UBL3 RB1 PKP4 KDM3B ANKHD1 CSE1L NF1 ATXN1 SEC23IP TMEM131 GARRE1 UTP14C	2.34e-06	429	159	13	M29
Coexpression	ACEVEDO_LIVER_CANCER_UP	DMTF1 DHX36 KDM5B NCOA6 AHCTF1 NCKIPSD FRS3 MR1 KDM3B SLU7 MCM3 ZHX2 FHIP2A EIF4ENIF1 ATXN1 SEC23IP SPDYE3 TCFL5 UTP14C	7.37e-06	972	159	19	M15709
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	DMTF1 NCOA6 VPS11 UBL3 SETD6 PKP4 KDM3B DAPK1 ANKHD1 CREB1 CSE1L AP2B1 ATXN1 MAPKAPK3 NADK MIOS TRAPPC10 TMEM131 TAF4 NFAT5 EPHB1	1.53e-05	1215	159	21	M41122
Coexpression	GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN	KDM3A NCOA6 DDX17 KDM3B GLE1 DDX23 CRBN FOXK1	3.17e-05	200	159	8	M5870
Coexpression	GSE43955_1H_VS_20H_ACT_CD4_TCELL_UP	UBL3 AXIN1 GTF2A1 EEF2 MED12L AKR1B15 IL4I1 AQR	3.17e-05	200	159	8	M9660
Coexpression	NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP	FOXM1 UBL3 RB1 SETD6 ANKHD1 ABHD4 CSE1L NF1 AP2B1 ANKRD12 GARRE1 AQR	3.52e-05	475	159	12	M40979
Coexpression	FEVR_CTNNB1_TARGETS_DN	FOXM1 DHX36 FRAS1 MCM3 CREB1 PABPC1 KIF20A ERGIC1 EEF1D NUP155 EIF2S3 ZFHX3 ZFP62	3.61e-05	555	159	13	M2343
Coexpression	DESCARTES_MAIN_FETAL_OLIGODENDROCYTES	GPR17 ADGRB1 OPCML CSPG5 PCDH15	4.08e-05	63	159	5	M40082
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	RBM33 ADGRB1 FRS3 ITGA8 ARHGEF12 GRIK2 LRP1B OPCML DUSP26 STXBP1 CELSR3 ZFHX4 CSPG5 PIP4K2B ZFHX3 ANKRD12 CTNND2 SPATA13 EPHB1	4.37e-05	1106	159	19	M39071
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HOPC	DOCK1 GPR17 UBL3 ADGRB1 CREB5 OPCML CSPG5 PCDH15 CTNND2 MIR9-1HG	8.44e-05	366	159	10	M39052
CoexpressionAtlas	DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000	DOCK1 DDX17 HIPK2 ITGA8 SLU7 SRCAP C2CD3 NUP155 SBNO1 MED12L NFAT5 AQR	1.83e-05	375	153	12	gudmap_developingKidney_e15.5_cortic collect duct_1000_k4
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 ZAN DNAH10 MROH2A LRP1B PCDH15 PKHD1 RP1	1.84e-07	169	160	8	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK1 GPR17 ZHX2 CREB5 ZFHX4 CSPG5 PCDH15 MIR9-1HG	3.25e-07	182	160	8	3cc61f5f7ad4a81eba3daf65e122880b5af3adc0
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK1 GPR17 ZHX2 CREB5 ZFHX4 CSPG5 PCDH15 MIR9-1HG	3.25e-07	182	160	8	5d909e4b5f662905bf1be9c686bbddc3e87d2be9
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 ZAN DNAH10 MROH2A LRP1B ZFHX4 PCDH15 PKHD1	3.53e-07	184	160	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 ZAN DNAH10 MROH2A LRP1B ZFHX4 PCDH15 PKHD1	3.53e-07	184	160	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 ZAN DNAH10 MROH2A LRP1B ZFHX4 PCDH15 PKHD1	3.53e-07	184	160	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	HIPK2 ITGA8 GRIK2 EEF2 PXDNL ZFHX3 PRDM6 EPHB1	3.83e-07	186	160	8	7def03dd856b765bd3f493288641981c4f7fd26e
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FRAS1 RGSL1 GPR17 ZAN CHAT CYP2G1P PKHD1 PRDM6	5.07e-07	193	160	8	315840bc48899f3a36d57b19197509de19716e3d
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	RB1 PKP4 ROR1 HIPK2 DAPK1 CREB5 ZFHX4 TMEM131	6.39e-07	199	160	8	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MUC16 CREB5 KIF20A PDZK1IP1 RP1 IL4I1 ALPK2	1.38e-06	153	160	7	499670e716fc85ce76630fc813cec86f8419f2a1
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GPR17 ADGRB1 GRIK2 LRP1B OPCML CSPG5 PCDH15	1.51e-06	155	160	7	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 DNAH10 MROH2A GRIK2 LRP1B ZFHX4 PKHD1	1.86e-06	160	160	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 DNAH10 MROH2A GRIK2 LRP1B ZFHX4 PKHD1	1.86e-06	160	160	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FRAS1 RGSL1 ZAN DNAH10 LRP1B PCDH15 PKHD1	2.02e-06	162	160	7	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK1 GPR17 ZHX2 CREB5 ZFHX4 CSPG5 PCDH15	4.37e-06	182	160	7	8a8b08ac4bb3cba3541dbe234e088703842285b9
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK1 GPR17 ZHX2 CREB5 ZFHX4 CSPG5 PCDH15	4.37e-06	182	160	7	e36766309c4d96a90d213ce37d3acef1029a3fdc
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK1 GPR17 ZHX2 CREB5 ZFHX4 CSPG5 PCDH15	4.87e-06	185	160	7	efc5d564f8793c751ba640aef60f761e4b081d3f
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK1 GPR17 ZHX2 CREB5 ZFHX4 CSPG5 PCDH15	4.87e-06	185	160	7	fba2dc46cd98ab9c78e788959c2121aa10d148b2
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ARHGEF12 CREB1 GTF2A1 TMEM131 ANKRD12 NFAT5 VPS13B	5.04e-06	186	160	7	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK1 HIPK2 ZHX2 CREB5 ZFHX4 PLEKHG3 SPATA13	5.23e-06	187	160	7	97e520705491c8f52a32025311a9fa7b9176979a
ToppCell	RA-10._Endothelium_II\|World / Chamber and Cluster_Paper	HIPK2 ITGA8 DAPK1 OPCML PCDH15 SH3RF3 GARRE1	5.60e-06	189	160	7	75c248b9de5e2fb7a0baa8cdbab516e575cc4394
ToppCell	RA-10._Endothelium_II\|RA / Chamber and Cluster_Paper	HIPK2 ITGA8 DAPK1 OPCML PCDH15 SH3RF3 GARRE1	5.60e-06	189	160	7	c81787a8c662db5d7814c583dd64562857629e81
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK1 PKP4 DAPK1 PXDNL PKHD1 RP1 NFAT5	5.60e-06	189	160	7	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B1\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	NCOA6 ARHGEF12 EIF4ENIF1 NUP155 MIOS AQR ZFP62	5.80e-06	190	160	7	2434b8ad2976eab7d9147012c28454ab29670709
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK1 GPR17 HIPK2 ZHX2 CREB5 ZFHX4 PLEKHG3	6.00e-06	191	160	7	2110a1dd10730ad7ee7a265fb1716ab3ddafcf4a
ToppCell	COVID-19-kidney-Epithelial_Doublet\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GOLGA6B SPATA31A6 LRP1B OPCML PCDH15 PKHD1	7.63e-06	130	160	6	1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	ROBO4 DDX17 PKP4 ARHGEF12 STXBP1 ZNF518B GARRE1	8.11e-06	200	160	7	eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 ROR1 ITGA8 GRIK2 OPCML PTPRR	2.57e-05	161	160	6	1b805f77790aeb8a71b08bfac2fe2eed7343258f
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B1\|367C / Donor, Lineage, Cell class and subclass (all cells)	NCOA6 EIF4ENIF1 NUP155 PLEKHG3 MIOS ZFP62	2.57e-05	161	160	6	f470b662566131dfe69a2fd01186ac8491196396
ToppCell	wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	DMTF1 FRAS1 DAPK1 MED12L RP1 CTNND2	2.95e-05	165	160	6	f6887c64af0f26e33316bc5587487e24d76ece2a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 ROR1 ITGA8 GRIK2 OPCML PTPRR	3.73e-05	172	160	6	08a3fe536b1b064c5ee7779bc2b1115a5963a26b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 ROR1 ITGA8 GRIK2 OPCML PTPRR	3.73e-05	172	160	6	553701349444eb366df3c11f54bb093434f153c6
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NCOA6 HIPK2 AXIN1 MAPKAPK3 MED12L TRAPPC10	3.73e-05	172	160	6	ebeda7ef181cac0109be750a98e7589c615d2724
ToppCell	droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HDAC9 MROH2A ROR1 CREB5 CTNND2 IL4I1	3.73e-05	172	160	6	b043d4f81dced7fb3326043f68474123be47cc5d
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MROH2A ROR1 MCM3 KIF20A CTNND2 IL4I1	3.85e-05	173	160	6	6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FRAS1 ATP7B DAPK1 GJA3 GARRE1 EPHB1	4.10e-05	175	160	6	f5451c29c487b998778e50349b3d774d5e20fd28
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 GRIK2 LRP1B ZFHX4 PKHD1 IL4I1	4.10e-05	175	160	6	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK1 GPR17 ZHX2 CREB5 CSPG5 PCDH15	5.11e-05	182	160	6	a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK1 GPR17 ZHX2 CREB5 CSPG5 PCDH15	5.11e-05	182	160	6	831b5ce46b41efe01c4db6016c2f43148611373d
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	HDAC9 MR1 SEC24D MAPKAPK3 YLPM1 FOXK1	5.26e-05	183	160	6	310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HDAC9 MR1 SEC24D MAPKAPK3 YLPM1 FOXK1	5.26e-05	183	160	6	fef51dcf180e6d4e136362c7e140ec5ef372e6d0
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK1 HIPK2 ZHX2 CREB5 PLEKHG3 SPATA13	5.43e-05	184	160	6	a2191dd5546efd357b23e625beb3c5820476f243
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	CFAP91 DNAH10 PPIL6 MUC16 RP1 MAP3K19	5.59e-05	185	160	6	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	CFAP91 DNAH10 PPIL6 MUC16 RP1 MAP3K19	5.59e-05	185	160	6	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 DAPK1 LRP1B CREB5 PKHD1 RP1	5.93e-05	187	160	6	87b3d0478693d4c54ff06b74e5903036b9c1ee6a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 DAPK1 LRP1B CREB5 PKHD1 RP1	5.93e-05	187	160	6	42a1267bfc27b4460b8409ada580a87c4385841c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 DAPK1 LRP1B CREB5 PKHD1 RP1	5.93e-05	187	160	6	64afdea159f5e67a1e5cea35ce898aae6e80aea5
ToppCell	facs-Aorta-Heart-3m-Endothelial-nan\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 GPR17 MROH2A PKP4 PTPRR GARRE1	5.93e-05	187	160	6	df0279b7e94e26f5541b0e2a0ce56befa96ec8ca
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	AHCTF1 NF1 TMEM131 ANKRD12 SPEN NFAT5	6.11e-05	188	160	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 ROR1 ITGA8 ZFHX3 SH3RF3 PRDM6	6.29e-05	189	160	6	7fbe855bfdb47d35e040b04a80fe4b729a3764e8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 ROR1 ITGA8 ZFHX3 SH3RF3 PRDM6	6.29e-05	189	160	6	06b35abecd29f902cf251fcc1f6ad33db7ab08a2
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK1 ZHX2 CREB5 ZFHX4 ZFHX3 SPATA13	6.29e-05	189	160	6	42ab4cc5fbf8580841f31889446fe4499df1a464
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK1 HIPK2 ZHX2 CREB5 ZFHX4 SPATA13	6.48e-05	190	160	6	07f21386ea6eb23416a537d2250e3042efe93fb0
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK1 HIPK2 ZHX2 CREB5 ZFHX4 SPATA13	6.48e-05	190	160	6	ae97df1b06bcd46c05759b53c35dc8fea97f4ac1
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	DDX17 AHCTF1 NUP155 TTC17 SPEN NFAT5	6.67e-05	191	160	6	9454f642c3621370fa23640b631301346b300950
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_B1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NCOA6 ARHGEF12 EIF4ENIF1 NUP155 MIOS ZFP62	6.67e-05	191	160	6	39ef8e1d7cc3ebb11717e8a55501515e3b72b177
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DOCK1 HIPK2 ZHX2 CREB5 ZFHX4 SPATA13	6.67e-05	191	160	6	2b056cbe2e82e056e1f798974999378460eb1d16
ToppCell	LPS_only-Endothelial-Endothelial-Vein\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HDAC9 PKP4 LRP1B IL4I1 SH3RF3 EPHB1	6.87e-05	192	160	6	52acaecd3703166f5ce3b328aff7c82bd142fee4
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Vein\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HDAC9 PKP4 LRP1B IL4I1 SH3RF3 EPHB1	6.87e-05	192	160	6	81baf1c4063469bb0c03a8602b40e387ba7b0dfb
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DAPK1 ZHX2 ANKHD1 ATXN1 NFAT5 VPS13B	7.07e-05	193	160	6	779276e775cb2492e8dd36436295a536084a6415
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HDAC9 PKP4 LRP1B IL4I1 SH3RF3 EPHB1	7.07e-05	193	160	6	7261c1ce30c796b61c6ec58e64a051baa24732ff
ToppCell	COVID-19-Epithelial-Ciliated_cells\|COVID-19 / Condition, Lineage and Cell class	CFAP91 DNAH10 PPIL6 MUC16 RP1 MAP3K19	7.27e-05	194	160	6	43be5fbd51dd58839cb03ca3ddd05a458e1ddb74
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 PKP4 DAPK1 LRP1B PKHD1 RP1	7.48e-05	195	160	6	6477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK1 ROR1 ZHX2 RANBP17 ATXN1 VPS13B	7.69e-05	196	160	6	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	COVID-19-kidney-TAL\|kidney / Disease (COVID-19 only), tissue and cell type	HDAC9 PKP4 DAPK1 LRP1B PKHD1 RP1	7.69e-05	196	160	6	04f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 PKP4 DAPK1 ZFHX4 PLEKHG3 PKHD1	7.69e-05	196	160	6	c7136b1c83bcf907eec3b02b151fa061298b6672
ToppCell	moderate-Lymphoid-Treg\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DDX17 HIPK2 PABPC1 CD6 ANKRD12 IL4I1	7.69e-05	196	160	6	9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da
ToppCell	Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ROR1 FRS3 LRP1B ZNF250 DUSP26 SPDYE3	8.14e-05	198	160	6	cbb63b255bdc92a557c5db1f08f7766ed9346607
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK1 ROR1 RANBP17 NF1 ATXN1 VPS13B	8.14e-05	198	160	6	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DDX17 MLLT10 PKHD1 TTC17 ALPK2 UTP14C	8.36e-05	199	160	6	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ROBO4 PKP4 ARHGEF12 STXBP1 ZNF518B GARRE1	8.60e-05	200	160	6	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ROBO4 PKP4 ARHGEF12 STXBP1 ZNF518B GARRE1	8.60e-05	200	160	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related-OPC\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	GPR17 CREB5 KIF20A ABHD4 PCDH15 MIR9-1HG	8.60e-05	200	160	6	02594c1edbc9f2cf831639cd83363abd2551cb94
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ROBO4 PKP4 ARHGEF12 NF1 STXBP1 IL4I1	8.60e-05	200	160	6	2d07237022b409c4fac6fcf99b68c8affb3007cd
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ROBO4 PKP4 ARHGEF12 STXBP1 ZNF518B GARRE1	8.60e-05	200	160	6	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	ROBO4 PKP4 ARHGEF12 STXBP1 IL4I1 GARRE1	8.60e-05	200	160	6	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	GPR17 CREB5 KIF20A ABHD4 PCDH15 MIR9-1HG	8.60e-05	200	160	6	46521d83b917b0357601db8783c8da6b73730d60
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	ROBO4 PKP4 ARHGEF12 STXBP1 ZNF518B GARRE1	8.60e-05	200	160	6	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ROBO4 PKP4 ARHGEF12 STXBP1 ZNF518B GARRE1	8.60e-05	200	160	6	f15fffefe372005c33e31845982e2d2714ac26af
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ROBO4 PKP4 ARHGEF12 STXBP1 ZNF518B GARRE1	8.60e-05	200	160	6	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ROBO4 PKP4 ARHGEF12 STXBP1 ZNF518B GARRE1	8.60e-05	200	160	6	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ROBO4 PKP4 ARHGEF12 STXBP1 IL4I1 GARRE1	8.60e-05	200	160	6	3585484c7e24e941708bee471ca607d8ccee74e6
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	ROBO4 PKP4 ARHGEF12 STXBP1 IL4I1 GARRE1	8.60e-05	200	160	6	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	COVID-19-kidney-Epithelial_(EC)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ITGA8 LRP1B OPCML PCDH15 PKHD1	1.19e-04	133	160	5	a8abb6b54862123961ae6defbf251ee6e9575258
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	DAPK1 ZHX2 CYP2G1P PCDH15 SPEN	1.28e-04	135	160	5	3351e8b9e417397c5fa9f856184ff24ce1a27242
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_3\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	MAGEL2 SRCAP CREB5 CD6 MIR9-1HG	1.32e-04	136	160	5	5e209185b5f6e9347829fc9066f0b2c3711df057
ToppCell	356C-Epithelial_cells-Epithelial-C_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	RGSL1 EIF3CL CELSR3 PDZK1IP1 PRDM6	1.67e-04	143	160	5	b74571d30def54a0524c8d95a3bc9d3439319eb4
ToppCell	356C-Epithelial_cells-Epithelial-C_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	RGSL1 EIF3CL CELSR3 PDZK1IP1 PRDM6	1.67e-04	143	160	5	5c81b238be53f010d691d0c59c1c29cb52222ed3
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-early_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MROH2A ZFHX4 GYS2 TMEM131 RP1	1.73e-04	144	160	5	1d05aa08603cba28c0c6511767e434c1f592a3aa
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-early_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MROH2A ZFHX4 GYS2 TMEM131 RP1	1.73e-04	144	160	5	d3f6f5da56794367ee3776bfd3a9dcf893efe0f0
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 RGSL1 LRP1B PCDH15 PKHD1	1.78e-04	145	160	5	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HDAC9 ROBO4 ROR1 ALPK2 EPHB1	2.89e-04	161	160	5	78cc5bc488bc47726195a649946d414e6bfabf94
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HDAC9 ROBO4 ROR1 ALPK2 EPHB1	2.98e-04	162	160	5	0fa93efc9c005d1e649b3f7069ae8641d6e41ed8
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	HDAC9 GPR17 PKP4 ABHD4 SH3RF3	3.33e-04	166	160	5	f7926ee266dcbf10df375cd921f1db5a2fa604f8
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FRAS1 CFAP91 SRF STXBP1 SPEN	3.33e-04	166	160	5	bcdaab49bde5beba750b76fdcc3781a3c12c4fff
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FRAS1 CFAP91 SRF STXBP1 SPEN	3.33e-04	166	160	5	5e3b998d740b24f790fad37350d704ca0ea10b77
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADGRB1 MUC16 DAPK1 IL4I1 ALPK2	3.42e-04	167	160	5	8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP91 DNAH10 PPIL6 RP1 MAP3K19	3.62e-04	169	160	5	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MORC1 FOXM1 TMPPE CD6 MAPKAPK3	3.62e-04	169	160	5	dbf9b1d52b29bf4b60bd23012cc1ea82d344747f
ToppCell	Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3-Excitatory_Neuron.Slc17a7.Nxph3-Hpcal1-Fos_(Entorhinal_cortex_(IEG))\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PABPC1 CD6 PTPRH IL4I1	3.66e-04	94	160	4	a4d0eefede392b55d17ae9995237a2278a570e42
Computational	Genes upregulated in subsets of cells of a given type within various tumors	DDX17 ARHGEF12 ATXN1 ZNF638 SPEN NFAT5	1.05e-05	50	109	6	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
Computational	Genes in the cancer module 49.	HDAC9 ZNF821 FRAS1 AHCTF1 RLN2 EEF1D C2CD3 STXBP1 GTF3C1 CSPG5 MIOS	1.78e-04	292	109	11	MODULE_49
Drug	Syrosingopine [84-36-6]; Up 200; 6uM; MCF7; HT_HG-U133A	KDM3A ZNF821 HIPK2 SRCAP ZNF250 SEC24D CD6 NADK GARRE1 MIR9-1HG	7.27e-07	192	153	10	6213_UP
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A	DOCK1 MLLT10 CREB5 SEC24D ATXN1 GLE1 PLEKHG3 PIP4K2B ANKRD12 CTNND2	7.99e-07	194	153	10	3725_DN
Drug	estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A	DDX17 SETD6 MR1 SEC24D NF1 SEC23IP NADK TRAPPC10 NFAT5	7.41e-06	196	153	9	1182_DN
Drug	Cefmetazole sodium salt [56796-39-5]; Up 200; 8.2uM; HL60; HT_HG-U133A	ROBO4 ATP7B SRF MR1 ARHGEF12 DUSP26 PVR CTNND2 MIR9-1HG	7.72e-06	197	153	9	2524_UP
Drug	troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A	HIPK2 MUC16 OPCML NF1 ZFHX4 PIP4K2B ZFHX3 AQR MIR9-1HG	7.72e-06	197	153	9	6991_UP
Drug	Indomethacin [53-86-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A	ZNF821 NCKIPSD CREB1 SLC4A2 ZNF250 AP2B1 PVR YLPM1 CTNND2	7.72e-06	197	153	9	5468_DN
Drug	dimethyl sulfate	FOXM1 SRF EEF2 NF1 GTF3C1 ACKR2 NFAT5	8.02e-06	107	153	7	CID000006497
Drug	chlorpromazine hydrochloride; Down 200; 1uM; HL60; HT_HG-U133A	DDX17 MR1 KDM3B ARHGEF12 NF1 ATXN1 PIP4K2C NFAT5 AQR	8.04e-06	198	153	9	1158_DN
Drug	Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; HL60; HG-U133A	ROBO4 RB1 HIPK2 DAPK1 MLLT10 ZHX2 YLPM1 NADK NFAT5	8.37e-06	199	153	9	1436_UP
Drug	Diazoxide [364-98-7]; Up 200; 17.4uM; HL60; HG-U133A	HDAC9 GATD3 DDX17 PKP4 MR1 CREB1 SEC24D NADK NFAT5	8.72e-06	200	153	9	1368_UP
Drug	AC1NDVEB	HDAC9 ATP7B SRR CREB1 EIF2S3 RP1	3.48e-05	91	153	6	CID004632235
Drug	Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	ZNF821 DDX17 NF1 GLE1 PVR SEC23IP NADK NFAT5	4.15e-05	188	153	8	4835_DN
Drug	MS-275; Down 200; 10uM; PC3; HT_HG-U133A	DDX17 SRF HIPK2 AXIN1 EIF4ENIF1 AP2B1 SEC23IP GARRE1	4.31e-05	189	153	8	7074_DN
Drug	Azathymine, 6 [932-53-6]; Down 200; 31.4uM; HL60; HT_HG-U133A	DDX17 PKP4 MLLT10 CSE1L NF1 SEC23IP NADK NFAT5	4.65e-05	191	153	8	2466_DN
Drug	Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; PC3; HT_HG-U133A	DOCK1 KDM5B SETD6 MLLT10 SRCAP NF1 NADK VPS13B	4.82e-05	192	153	8	7155_DN
Drug	Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A	DDX17 PKP4 HIPK2 MLLT10 SBNO1 NADK SPEN NFAT5	4.82e-05	192	153	8	4268_DN
Drug	Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A	DDX17 RB1 DAPK1 NF1 AP2B1 PLEKHG3 PVR MIR9-1HG	5.00e-05	193	153	8	3845_UP
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; PC3; HT_HG-U133A	ROR1 SRF HIPK2 MLLT10 GTF2A1 NF1 CELSR3 QSER1	5.00e-05	193	153	8	4443_DN
Drug	Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A	MR1 ARHGEF12 MLLT10 ABHD4 CSE1L PIP4K2B NFAT5 GARRE1	5.00e-05	193	153	8	5024_DN
Drug	Florfenicol [73231-34-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	FRS3 AXIN1 ABHD4 ZNF250 CD6 CELSR3 ZFHX3 QSER1	5.38e-05	195	153	8	6701_DN
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; PC3; HT_HG-U133A	PKP4 ARHGEF12 GTF2A1 CD6 NF1 AP2B1 PTPRR SEC23IP	5.38e-05	195	153	8	4298_UP
Drug	Myosmine [532-12-7]; Down 200; 27.4uM; PC3; HT_HG-U133A	ZNF821 MED9 SRF AP2B1 PLEKHG3 MIOS CTNND2 MIR9-1HG	5.38e-05	195	153	8	3737_DN
Drug	Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; HL60; HG-U133A	HIPK2 DAPK1 CREB1 ABHD4 NF1 GLE1 YLPM1 MIR9-1HG	5.38e-05	195	153	8	1371_DN
Drug	Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; PC3; HT_HG-U133A	FRS3 SRF CHAT SRCAP CD6 ACKR2 CTNND2 EPHB1	5.38e-05	195	153	8	4267_UP
Drug	Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	DOCK1 ZNF821 RB1 MED9 ZNF250 NF1 NADK CTNND2	5.38e-05	195	153	8	6770_DN
Drug	Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; HL60; HG-U133A	MED9 MLLT10 ZNF250 STXBP1 YLPM1 ANKRD12 PIP4K2C NFAT5	5.58e-05	196	153	8	1403_DN
Drug	PNU-0230031 [267429-39-0]; Up 200; 1uM; PC3; HT_HG-U133A	DDX17 PKP4 HIPK2 GTF2A1 PTPRR PLEKHG3 ACKR2 CTNND2	5.58e-05	196	153	8	4291_UP
Drug	Metergoline [17692-51-2]; Down 200; 10uM; PC3; HT_HG-U133A	SETD6 ROR1 GTF2A1 CSE1L CD6 NF1 PVR QSER1	5.58e-05	196	153	8	6744_DN
Drug	Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; PC3; HT_HG-U133A	MR1 GRIK2 CREB1 ABHD4 RANBP17 PTPRR QSER1 NFAT5	5.58e-05	196	153	8	2121_DN
Drug	Dydrogesterone [152-62-5]; Down 200; 12.8uM; PC3; HT_HG-U133A	FRS3 GRIK2 AXIN1 GTF2A1 PTPRH CSPG5 PVR MIR9-1HG	5.58e-05	196	153	8	4254_DN
Drug	Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; PC3; HT_HG-U133A	HDAC9 ROR1 MLLT10 AXIN1 GTF2A1 NF1 PVR QSER1	5.78e-05	197	153	8	6737_DN
Drug	Ursolic acid [77-52-1]; Down 200; 8.8uM; PC3; HT_HG-U133A	DMTF1 AXIN1 CSE1L ATXN1 GLE1 PLEKHG3 TRAPPC10 PIP4K2B	5.78e-05	197	153	8	2067_DN
Drug	Pentylenetetrazole [54-95-5]; Up 200; 29uM; HL60; HG-U133A	ARHGEF12 SRR SRCAP RANBP17 CD6 NF1 PLEKHG3 YLPM1	5.78e-05	197	153	8	1408_UP
Drug	C75; Down 200; 10uM; PC3; HT_HG-U133A	DOCK1 GPR17 MED9 ROR1 MLLT10 SRCAP CREB5 PTPRH	5.78e-05	197	153	8	6428_DN
Drug	Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A	DOCK1 AXIN1 ABHD4 NADK QSER1 CTNND2 NFAT5 AQR	5.78e-05	197	153	8	2853_DN
Drug	Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A	DDX17 PKP4 FRS3 HIPK2 SRCAP NF1 SPEN NFAT5	5.99e-05	198	153	8	4282_DN
Drug	Rilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; PC3; HT_HG-U133A	RB1 PKP4 FRS3 RANBP17 PTPRH PVR TRAPPC10 ZFHX3	5.99e-05	198	153	8	5107_UP
Drug	Dienestrol [84-17-3]; Up 200; 15uM; PC3; HT_HG-U133A	ZNF821 GRIK2 MLLT10 SRCAP OPCML CD6 NF1 PTPRR	5.99e-05	198	153	8	5727_UP
Drug	Iodipamide [606-17-7]; Up 200; 3.6uM; PC3; HT_HG-U133A	ZNF821 FRS3 ARHGEF12 GRIK2 NF1 PTPRH PLEKHG3 ZFHX3	6.20e-05	199	153	8	5085_UP
Drug	Heliotrine [303-33-3]; Up 200; 12.8uM; PC3; HT_HG-U133A	KDM5B SRF ITGA8 LCT CD6 NF1 ZFHX3 CTNND2	6.20e-05	199	153	8	4277_UP
Drug	Isometheptene mucate; Down 200; 8.2uM; MCF7; HT_HG-U133A	DOCK1 HIPK2 SRCAP CD6 NF1 PVR NADK CTNND2	6.20e-05	199	153	8	5502_DN
Drug	Ethosuximide [77-67-8]; Up 200; 28.4uM; PC3; HT_HG-U133A	HDAC9 FRS3 MLLT10 OPCML NF1 CSPG5 QSER1 CTNND2	6.20e-05	199	153	8	7308_UP
Drug	Felbinac [5728-52-9]; Down 200; 18.8uM; PC3; HT_HG-U133A	ZNF821 GPR17 DDX17 MLLT10 CREB1 OPCML GLE1 PVR	6.43e-05	200	153	8	4639_DN
Drug	Laudanosine (R,S) [1699-51-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A	ZNF821 AXIN1 CD6 NF1 PLEKHG3 TRAPPC10 GARRE1 AQR	6.43e-05	200	153	8	7030_UP
Drug	estradiol, USP; Down 200; 0.01uM; PC3; HG-U133A	HDAC9 RB1 MR1 HIPK2 ARHGEF12 AXIN1 PIP4K2B AQR	6.43e-05	200	153	8	665_DN
Drug	CID5320302	RB1 PCDH15	1.34e-04	3	153	2	CID005320302
Drug	beta-methyllanthionine	VPS11 LCT	1.34e-04	3	153	2	CID000191096
Drug	AC1L9NO4	FOXM1 SRR ACKR2	1.89e-04	17	153	3	CID000449826
Drug	Cephaeline dihydrochloride heptahydrate [6487-30-5]; Down 200; 6uM; PC3; HT_HG-U133A	UBL3 HIPK2 ARHGEF12 CSE1L SBNO1 PIP4K2B AQR	2.13e-04	179	153	7	4651_DN
Drug	AC1L2E0P	FOXM1 HDAC9 NCOA6 DDX17 RB1 MLLT10 CREB1 GTF2A1 TAF4	2.40e-04	307	153	9	CID000019390
Drug	4-(1-naphthylvinyl)pyridine	CHAT TCFL5	2.67e-04	4	153	2	CID000027841
Drug	2-benzoylethyl)trimethylammonium	CHAT TCFL5	2.67e-04	4	153	2	CID000152676
Drug	thioridazine hydrochloride; Up 200; 10uM; PC3; HT_HG-U133A	HDAC9 ARHGEF12 OPCML SEC24D ATXN1 PTPRR QSER1	2.88e-04	188	153	7	5921_UP
Drug	Demecolcine	HDAC9 DDX17 SETD6 BTBD10 MR1 ANKHD1 ZBTB24 NUP155 ATXN1 PTPRR ZNF638 MIOS TRAPPC10 ANKRD12 NFAT5 ALPK2	2.88e-04	878	153	16	ctd:D003703
Drug	Ketoconazole [65277-42-1]; Up 200; 7.6uM; HL60; HT_HG-U133A	ZNF821 PKP4 HIPK2 MLLT10 SRCAP PVR ACKR2	2.97e-04	189	153	7	1285_UP
Drug	Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A	DDX17 PKP4 HIPK2 PTPRH SBNO1 SPEN NFAT5	3.07e-04	190	153	7	4307_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	DDX17 PKP4 HIPK2 GTF2A1 SPEN NFAT5 MIR9-1HG	3.07e-04	190	153	7	4322_DN
Drug	Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A	ZNF821 ARHGEF12 SRCAP NF1 NADK QSER1 GARRE1	3.17e-04	191	153	7	7339_UP
Drug	Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A	DDX17 PKP4 HIPK2 ZBTB24 YLPM1 SPEN NFAT5	3.17e-04	191	153	7	4273_DN
Drug	Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; HL60; HG-U133A	DMTF1 HDAC9 HIPK2 CREB1 YLPM1 SEC23IP ANKRD12	3.17e-04	191	153	7	1418_DN
Drug	Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A	ATP7B MR1 SRCAP ABHD4 NF1 PVR CTNND2	3.17e-04	191	153	7	3890_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	MLLT10 SLC4A2 GTF2A1 PVR CTNND2 NFAT5 AQR	3.17e-04	191	153	7	5567_DN
Drug	Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A	SRF ARHGEF12 ZNF250 NF1 AP2B1 NADK NFAT5	3.27e-04	192	153	7	7427_DN
Drug	Tetrahydroalstonine [6474-90-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A	SETD6 PKP4 RAB11A ZNF592 NADK ACKR2 AQR	3.37e-04	193	153	7	6209_UP
Drug	Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A	DDX17 HIPK2 ARHGEF12 GTF2A1 PLEKHG3 SPEN NFAT5	3.37e-04	193	153	7	4321_DN
Drug	Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; PC3; HT_HG-U133A	ZNF821 GPR17 RB1 DAPK1 SRCAP NF1 CTNND2	3.37e-04	193	153	7	3811_UP
Drug	carbamazepine; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	MLLT10 ZNF250 CSE1L GLE1 PIP4K2B SPEN NFAT5	3.37e-04	193	153	7	835_DN
Drug	Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; MCF7; HT_HG-U133A	DMTF1 RB1 AXIN1 CSE1L NADK TRAPPC10 CTNND2	3.37e-04	193	153	7	6783_DN
Drug	Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; PC3; HT_HG-U133A	GPR17 MR1 CREB1 AXIN1 ATXN1 PTPRR GLE1	3.37e-04	193	153	7	1830_UP
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	PKP4 CREB1 ZNF250 NF1 AP2B1 YLPM1 NFAT5	3.48e-04	194	153	7	7481_DN
Drug	Harmine hydrochloride [343-27-1]; Up 200; 16uM; PC3; HT_HG-U133A	MORC1 KDM5B SETD6 MLLT10 ZNF250 NF1 PVR	3.48e-04	194	153	7	5855_UP
Drug	Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; MCF7; HT_HG-U133A	MORC1 MR1 CHAT OPCML CD6 ACKR2 EPHB1	3.48e-04	194	153	7	5609_UP
Drug	Cholecalciferol [67-97-0]; Down 200; 10.4uM; PC3; HT_HG-U133A	MED9 GRIK2 ABHD4 CD6 NF1 CELSR3 ZFHX3	3.48e-04	194	153	7	6656_DN
Drug	Nilutamide [63612-50-0]; Down 200; 12.6uM; PC3; HT_HG-U133A	FRS3 MLLT10 CD6 NF1 GLE1 PVR ZFHX3	3.48e-04	194	153	7	6763_DN
Drug	Nitrofurantoin [67-20-9]; Down 200; 16.8uM; PC3; HT_HG-U133A	HDAC9 GPR17 PLEKHG3 CSPG5 NADK ZFHX3 GARRE1	3.48e-04	194	153	7	3674_DN
Drug	Nifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A	MR1 HIPK2 SRCAP KIF20A ATXN1 ZNF592 NADK	3.48e-04	194	153	7	1814_DN
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	MR1 HIPK2 SEC24D NF1 PIP4K2B QSER1 VPS13B	3.48e-04	194	153	7	3539_DN
Drug	Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; MCF7; HT_HG-U133A	ZNF821 HIPK2 SRR SRCAP GTF2A1 NF1 PVR	3.48e-04	194	153	7	4387_DN
Drug	Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; PC3; HT_HG-U133A	DDX17 MR1 CREB1 AXIN1 NF1 PVR SEC23IP	3.59e-04	195	153	7	5112_DN
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A	ZNF821 DDX17 UBL3 EEF1D NF1 PIP4K2B QSER1	3.59e-04	195	153	7	2308_DN
Drug	Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; HL60; HT_HG-U133A	SETD6 SRR AXIN1 SLC4A2 ZNF250 CSPG5 NADK	3.59e-04	195	153	7	2151_DN
Drug	Triflusal [322-79-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A	PKP4 SRF GTF2A1 NF1 CELSR3 PVR NFAT5	3.59e-04	195	153	7	7451_DN
Drug	estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A	MLLT10 SRCAP RANBP17 SEC24D NF1 CELSR3 MIR9-1HG	3.59e-04	195	153	7	6200_DN
Drug	Fluspirilen [1841-19-6]; Down 200; 8.4uM; PC3; HT_HG-U133A	DOCK1 MR1 SRCAP CREB5 CD6 NF1 CELSR3	3.59e-04	195	153	7	6662_DN
Drug	Crotamiton [483-63-6]; Down 200; 19.6uM; PC3; HT_HG-U133A	GPR17 DDX17 FRS3 ARHGEF12 CD6 NF1 PVR	3.70e-04	196	153	7	4628_DN
Drug	Panthenol (D) [81-13-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A	DOCK1 AXIN1 NF1 PVR NADK PIP4K2B CTNND2	3.70e-04	196	153	7	7455_DN
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A	MED9 SEC24D NF1 CELSR3 PVR ZFHX3 CTNND2	3.70e-04	196	153	7	3716_DN
Drug	Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; HL60; HG-U133A	HIPK2 DAPK1 AP2B1 NADK NFAT5 GARRE1 MIR9-1HG	3.70e-04	196	153	7	1370_DN
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; HL60; HG-U133A	PKP4 RAB11A KIF20A ABHD4 GTF3C1 AP2B1 PIP4K2B	3.70e-04	196	153	7	2005_DN
Drug	Moxisylyte hydrochoride [964-52-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A	DDX17 HIPK2 AXIN1 NF1 PIP4K2B GARRE1 MIR9-1HG	3.70e-04	196	153	7	7015_UP
Drug	Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; PC3; HT_HG-U133A	GATD3 DDX17 SRCAP AP2B1 PLEKHG3 SEC23IP TRAPPC10	3.70e-04	196	153	7	2065_DN
Drug	Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; PC3; HT_HG-U133A	ZNF821 GRIK2 NF1 CELSR3 PLEKHG3 PIP4K2B CTNND2	3.70e-04	196	153	7	3726_DN
Drug	(-)-depudecin; Down 200; 1uM; MCF7; HT_HG-U133A_EA	DMTF1 ATP7B PKP4 RANBP17 GLE1 PIP4K2B NFAT5	3.70e-04	196	153	7	874_DN
Drug	Dosulepin hydrochloride [897-15-4]; Up 200; 12uM; HL60; HG-U133A	UBL3 RB1 CREB1 NF1 ATXN1 YLPM1 NFAT5	3.70e-04	196	153	7	1713_UP
Drug	Tremorine dihydrochloride [300-68-5]; Up 200; 15uM; MCF7; HT_HG-U133A	CHAT SRCAP CSE1L NF1 NADK ZFHX3 QSER1	3.70e-04	196	153	7	6273_UP
Drug	Dequalinium dichloride [522-51-0]; Down 200; 7.6uM; MCF7; HT_HG-U133A	DOCK1 SLC4A2 GTF2A1 CSE1L NF1 PIP4K2B AQR	3.70e-04	196	153	7	5396_DN
Drug	Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A	ZNF821 CREB1 GTF2A1 NADK TRAPPC10 NFAT5 AQR	3.70e-04	196	153	7	4844_DN
Drug	Isosorbide dinitrate [87-33-2]; Down 200; 17uM; HL60; HT_HG-U133A	SRR MLLT10 SRCAP SEC24D CSE1L PLEKHG3 PVR	3.70e-04	196	153	7	2183_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	RB1 SRF SRCAP NF1 PVR MIR9-1HG MAP3K19	3.70e-04	196	153	7	3847_UP
Drug	2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A_EA	ABHD4 RLN2 STXBP1 ATXN1 CSPG5 PVR YLPM1	3.70e-04	196	153	7	1078_UP
Disease	MEHMO syndrome (implicated_via_orthology)	EIF2S3B EIF2S3	2.64e-05	2	152	2	DOID:0060801 (implicated_via_orthology)
Disease	Undifferentiated carcinoma of ovary	ALPK2 EPHB1	2.64e-05	2	152	2	C0346167
Disease	smoking status measurement	MORC1 SRR GRIK2 MLLT10 OPCML RANBP17 PXDNL CSPG5 PCDH15 PKHD1 MED12L ZFHX3 QSER1 CTNND2 NFAT5 CRBN EPHB1	1.06e-04	1160	152	17	EFO_0006527
Disease	neuroticism measurement, cognitive function measurement	MLLT10 CREB1 LRP1B OPCML CSE1L GTF3C1 YLPM1 ZNF638 ZFHX3 CTNND2 EPHB1	1.78e-04	566	152	11	EFO_0007660, EFO_0008354
Disease	Neoplasm of the genitourinary tract	RB1 OPCML ZFHX3	2.51e-04	24	152	3	cv:C0042065
Disease	Choledochal Cyst, Type I	SLC4A2 PKHD1	2.61e-04	5	152	2	C0009439
Disease	Choledochal Cyst, Type II	SLC4A2 PKHD1	2.61e-04	5	152	2	C1257796
Disease	Choledochal Cyst, Type III	SLC4A2 PKHD1	2.61e-04	5	152	2	C1257797
Disease	Choledochal Cyst, Type IV	SLC4A2 PKHD1	2.61e-04	5	152	2	C1257798
Disease	Choledochal Cyst, Type V	SLC4A2 PKHD1	2.61e-04	5	152	2	C1257799
Disease	Choledochal Cyst	SLC4A2 PKHD1	2.61e-04	5	152	2	C0008340
Disease	body weight	DOCK1 DMTF1 UBL3 SETD6 ARHGEF12 GRIK2 MLLT10 LRP1B OPCML AXIN1 PTPRR PDZK1IP1 PCDH15 ZNF638 NADK ZFHX3 EPHB1	2.83e-04	1261	152	17	EFO_0004338
Disease	response to gemcitabine	DOCK1 DAPK1 CREB5	2.84e-04	25	152	3	GO_0036272
Disease	smoking cessation	RBM33 OPCML STXBP1 EIF4ENIF1 CYP2G1P PCDH15 ZFHX3 NFAT5	2.95e-04	325	152	8	EFO_0004319
Disease	hypopituitarism (implicated_via_orthology)	EIF2S3B EIF2S3	3.90e-04	6	152	2	DOID:9406 (implicated_via_orthology)
Disease	ovarian neoplasm	ATP7B ITGA8 MUC16 GRIK2 OPCML	6.65e-04	134	152	5	C0919267
Disease	Schizophrenia	HDAC9 ITGA8 CHAT SRR GRIK2 CREB1 OPCML STXBP1 SBNO1 CSPG5 PIP4K2C CTNND2 C9orf72	6.78e-04	883	152	13	C0036341
Disease	atrial fibrillation	KDM3A DNAH10 CREB5 ZFHX4 ATXN1 ZFHX3 SPEN PRDM6	7.06e-04	371	152	8	EFO_0000275
Disease	lifestyle measurement, anxiety disorder measurement	ROR1 GRIK2 FHIP2A OPCML ACKR2	7.35e-04	137	152	5	EFO_0007795, EFO_0010724
Disease	Malignant neoplasm of ovary	ATP7B ITGA8 MUC16 GRIK2 OPCML	7.35e-04	137	152	5	C1140680
Disease	colon cancer (is_implicated_in)	KDM3A NCOA6 LRP1B	8.45e-04	36	152	3	DOID:219 (is_implicated_in)
Disease	obesity (implicated_via_orthology)	KDM3A DNAH10 ABHD4 ZFHX4 MED12L ZFHX3	8.95e-04	215	152	6	DOID:9970 (implicated_via_orthology)
Disease	leukodystrophy (implicated_via_orthology)	EIF2S3B EIF2S3	9.27e-04	9	152	2	DOID:10579 (implicated_via_orthology)
Disease	Autosomal Recessive Polycystic Kidney Disease	SLC4A2 PKHD1	9.27e-04	9	152	2	C0085548
Disease	amyotrophic lateral sclerosis	DOCK1 CREB5 ERGIC1 ATXN1 C9orf72	9.48e-04	145	152	5	MONDO_0004976
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	ROR1 DAPK1 MLLT10 LRP1B EEF2	1.04e-03	148	152	5	C0279702
Disease	mean arterial pressure	HDAC9 PKP4 HIPK2 ARHGEF12 DAPK1 PXDNL PKHD1 ZFHX3 PRDM6	1.17e-03	499	152	9	EFO_0006340
Disease	oral microbiome measurement	HDAC9 FRAS1 GRIK2	1.33e-03	42	152	3	EFO_0801229
Disease	Malignant neoplasm of breast	FOXM1 KDM3A NCOA6 ATP7B RB1 ROR1 GRIK2 PABPC1 GTF2A1 EEF2 NF1 SBNO1 SPEN VPS13B	1.36e-03	1074	152	14	C0006142
Disease	autosomal recessive polycystic kidney disease (biomarker_via_orthology)	SLC4A2 PKHD1	1.41e-03	11	152	2	DOID:0110861 (biomarker_via_orthology)
Disease	S-warfarin measurement	MAGEL2 ZHX2 LRP1B CREB5	1.62e-03	97	152	4	EFO_0803323
Disease	Gastrointestinal Stromal Sarcoma	RB1 HIPK2 C2CD3	1.84e-03	47	152	3	C3179349
Disease	lung non-small cell carcinoma (is_marker_for)	KDM3B AXIN1 EEF2 NF1 ZFHX3	1.87e-03	169	152	5	DOID:3908 (is_marker_for)
Disease	cannabis dependence measurement	SEC24D PKHD1 CTNND2	1.96e-03	48	152	3	EFO_0008457
Disease	hepatocellular carcinoma (implicated_via_orthology)	FOXM1 ATP7B SRF	2.08e-03	49	152	3	DOID:684 (implicated_via_orthology)
Disease	Gastrointestinal Stromal Tumors	RB1 HIPK2 C2CD3	2.20e-03	50	152	3	C0238198
Disease	pulse pressure measurement	HDAC9 RBM33 SETD6 ARHGEF12 SRCAP CREB5 ZFHX4 ATXN1 PXDNL ZNF638 NADK ZFHX3 CTNND2 NFAT5 GARRE1 PRDM6	2.27e-03	1392	152	16	EFO_0005763
Disease	neuritic plaque measurement	DOCK1 HDAC9 GRIK2 PXDNL RP1 SPATA13 EPHB1	2.28e-03	349	152	7	EFO_0006798
Disease	Unipolar Depression	MORC1 HDAC9 ATP7B CREB1 PTPRR CTNND2	2.30e-03	259	152	6	C0041696
Disease	lysophosphatidylcholine 15:0 measurement	LRP1B PKHD1	2.30e-03	14	152	2	EFO_0020941
Disease	Antihypertensive use measurement	HDAC9 PKP4 MCM3 PXDNL NFAT5 PRDM6	2.58e-03	265	152	6	EFO_0009927
Disease	Glioblastoma Multiforme	GRIK2 NF1 MAPKAPK3 CTNND2	2.64e-03	111	152	4	C1621958
Disease	heart failure	ZNF592 ZNF638 ZFHX3 C9orf72 NFAT5	2.76e-03	185	152	5	EFO_0003144
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	DNAH10 MLLT10 RANBP17 YLPM1 PKHD1 ZFHX3 NFAT5	2.89e-03	364	152	7	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	Ischemic stroke, fibrinogen measurement	HDAC9 GYS2 TTC17	2.89e-03	55	152	3	EFO_0004623, HP_0002140
Disease	facial morphology measurement	HDAC9 ITGA8 OPCML PXDNL PKHD1 ZFHX3 CTNND2 VPS13B	2.96e-03	466	152	8	EFO_0007841
Disease	Abnormal behavior	KDM3B MED12L	3.02e-03	16	152	2	C0233514
Disease	ovarian cancer (is_implicated_in)	ITGA8 MUC16 OPCML	3.04e-03	56	152	3	DOID:2394 (is_implicated_in)
Disease	blood osmolality measurement	GRIK2 PKHD1 NFAT5	3.36e-03	58	152	3	EFO_0007967
Disease	myeloid white cell count	HDAC9 DNAH10 ARHGEF12 LCT CREB5 GTF2A1 GTF3C1 ATXN1 MED12L ZFHX3 RP1 ACKR2	3.45e-03	937	152	12	EFO_0007988
Disease	Alzheimer disease, polygenic risk score	FRAS1 ATP7B ZAN NCKIPSD PPIL6 SBNO1 PVR PKHD1 NFAT5	3.45e-03	586	152	9	EFO_0030082, MONDO_0004975
Disease	alcohol use disorder (implicated_via_orthology)	KDM3A KDM5B DDX17 KDM3B STXBP1	3.46e-03	195	152	5	DOID:1574 (implicated_via_orthology)
Disease	age at onset, Parkinson disease	TMEM175 QSER1	3.82e-03	18	152	2	EFO_0004847, MONDO_0005180
Disease	body fat percentage	DNAH10 MLLT10 RANBP17 CSE1L YLPM1 PKHD1 ZFHX3 NFAT5	3.91e-03	488	152	8	EFO_0007800
Disease	Acute Myeloid Leukemia, M1	DAPK1 MLLT10 NF1 PVR	4.05e-03	125	152	4	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	DAPK1 MLLT10 NF1 PVR	4.05e-03	125	152	4	C1879321
Disease	Sarcomatoid Renal Cell Carcinoma	DAPK1 MLLT10 LRP1B EEF2	4.41e-03	128	152	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	DAPK1 MLLT10 LRP1B EEF2	4.41e-03	128	152	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	DAPK1 MLLT10 LRP1B EEF2	4.41e-03	128	152	4	C1266044
Disease	Papillary Renal Cell Carcinoma	DAPK1 MLLT10 LRP1B EEF2	4.41e-03	128	152	4	C1306837
Disease	Renal Cell Carcinoma	DAPK1 MLLT10 LRP1B EEF2	4.41e-03	128	152	4	C0007134
Disease	mood instability measurement	LRP1B YLPM1 FOXK1 EPHB1	4.41e-03	128	152	4	EFO_0008475
Disease	fish consumption measurement	CREB1 NF1 ATXN1	4.44e-03	64	152	3	EFO_0010139
Disease	neutrophil percentage of leukocytes	HDAC9 RAB11A PPIL6 LCT CREB5 GTF3C1 SBNO1 ATXN1 TMEM131	4.48e-03	610	152	9	EFO_0007990
Disease	word reading	ATXN1 PCDH15 ZFHX3	4.63e-03	65	152	3	EFO_0005300
Disease	BRCAX breast cancer	DOCK1 UBL3	4.71e-03	20	152	2	EFO_0009443
Disease	Prostatic Neoplasms	ATP7B RB1 LRP1B SLC4A2 RLN2 PDZK1IP1 PVR ZFHX3 SPEN	4.77e-03	616	152	9	C0033578
Disease	Malignant neoplasm of prostate	ATP7B RB1 LRP1B SLC4A2 RLN2 PDZK1IP1 PVR ZFHX3 SPEN	4.77e-03	616	152	9	C0376358
Disease	mean corpuscular hemoglobin concentration	HDAC9 ATP7B RAB11A CREB1 PABPC1 AXIN1 SLC4A2 GTF2A1 ATXN1 PDZK1IP1 ZNF638 ANKRD12 VPS13B	4.81e-03	1105	152	13	EFO_0004528
Disease	keratoconus	LRP1B PKHD1 MAP3K19	4.84e-03	66	152	3	MONDO_0015486
Disease	common carotid intimal medial thickness	RGSL1 SLU7 CTNND2	5.04e-03	67	152	3	EFO_0004860

Protein segments in the cluster

Peptide	Gene	Start	Entry
PEVIHMLQHQFPSVQ	PKP4	531	Q99569
SIPDMVFVQTHENPK	ACKR2	176	O00590
QVVLVATHADIMNVP	DAPK1	881	P53355
QQTLPGVAHQVVEQM	SLC4A2	391	P04920
PQDQLVVMHPTPQVD	BTBD10	436	Q9BSF8
AIHTPLMPNQSIDVS	AP2B1	771	P63010
TLQAPHEVLGQSIMP	CSPG5	126	O95196
QMPQTRLIHLSTAPE	ADGRB1	1371	O14514
MGHEAEIQPAILQVP	ALPK2	1441	Q86TB3
NEPHQSMVLDHNIIP	ATP7B	676	P35670
QRQSLPPVTTHNMID	GYS2	436	P54840
MAPLLVSPQTVQTNH	GPR17	191	Q13304
TLPLQLFHPQEVSMV	CRBN	96	Q96SW2
VSPEQNDRTPLVMVH	ABHD4	61	Q8TB40
VLPHMQENQPLSETS	GLE1	56	Q53GS7
ERPSHEVQIIKNMPQ	AQR	1346	O60306
NTAPVNTVMDSPVHL	ANKRD12	1391	Q6UB98
AMVQAQIHLPVVQSV	ATXN1	546	P54253
PPEQHTMVSLPSVQH	CBLL2	181	Q8N7E2
SPMAALQIPVQITHV	DMTF1	456	Q9Y222
LRTSQVPDVMAPQHD	MIR9-1HG	86	Q13536
ELPEVIQMLQHQFPS	CTNND2	551	Q9UQB3
APQTQHVSPMRQVEP	EEF1D	126	P29692
PMTGIPAVESTHQQQ	ARHGEF12	1441	Q9NZN5
MSHAVTIEEPQAQPQ	CFAP91	1	Q7Z4T9
PHTPVRTVMNTIQQL	RB1	371	P06400
TQDHMSFIINLEPPV	RANBP17	896	Q9H2T7
ENDMSPSNNVVPIHV	RAB11A	186	P62491
PMSQPQFRPHVQTAQ	RBM33	651	Q96EV2
RVQSPQQIVHPFLQM	QSER1	756	Q2KHR3
TLSEMQPALPQLQQH	RLN2	101	P04090
DNPTVQQIVQLSPVM	GOLGA6A	676	Q9NYA3
AQPQVTMQQPAVHVQ	PABPC1	526	P11940
TMQQPAVHVQGQEPL	PABPC1	531	P11940
VNIPLEVMEPSHNKQ	MORC1	401	Q86VD1
ALPVMVNHQHLPTTI	CD6	431	P30203
DTNVVIQQAMPSPQS	CREB5	126	Q02930
QAAPSTVPIMHQVSA	EPHB1	431	P54762
QLIHPAETNTMVPRT	MUC16	11491	Q8WXI7
HPVDDSLPVVQNLGM	FRAS1	2306	Q86XX4
TSSVQIIEEHPPMIQ	HIPK2	141	Q9H2X6
IIEEHPPMIQNNASG	HIPK2	146	Q9H2X6
IPHQPMGIIAVANDT	LRP1B	2446	Q9NZR2
MQPPSLHAITSQQQL	MED12L	1866	Q86YW9
VPHEIPTSMEFQEVQ	MAGEL2	596	Q9UJ55
QSMVVPQTPLHTARV	MAPKAPK3	306	Q16644
EDRQDVVLQVHMPPS	HMCN2	2066	Q8NDA2
LEMVAHISEHPNQQP	KIAA1109	4476	Q2LD37
EVQIFAPDVPQMHVI	GATD3B	76	A0A0B4J2D5
VASQFQMHPTPVRIQ	DSG4	361	Q86SJ6
LQNPQTIMHIQDPAS	NADK	81	O95544
QEEPEPAHMILTVGN	PDZK1IP1	56	Q13113
SATAQPQNPDMTHVI	ERGIC1	136	Q969X5
QSHEPENLMPTQIIP	KDM3B	1086	Q7LBC6
QPMVILHHQTLPAST	LCT	126	P09848
PDLLHQLVTIMNPNT	KDM5B	546	Q9UGL1
PDVQKILEHMPVSNQ	DDX23	561	Q9BUQ8
QLELVPTQNERPIHM	PPIL6	286	Q8IXY8
DNPTVQQIVQLSPVM	GOLGA6B	676	A6NDN3
AFQQQAPISHIQTPM	NFAT5	1181	O94916
APISHIQTPMLSQEQ	NFAT5	1186	O94916
HPMIINLENKTCQVP	ITGA8	496	P53708
ISTMPGIHLSPEQQQ	MED9	101	Q9NWA0
IPITDSPVVVQQHML	NUP155	481	O75694
VHSMVQPEQAPKVLN	PTPRR	286	Q15256
QRMEIIPLNQHTSDP	PRDM6	181	Q9NQX0
SRVHLIVQVPPQIMN	OPCML	126	Q14982
HQTITIQEMPEKAPA	MCM3	196	P25205
VSIQQTNMVPPHVQA	NCOA6	821	Q14686
DPPMNIHSIVVQVQC	PCDH15	106	Q96QU1
MLDHIPQVPQQTTVL	PXDNL	41	A1KZ92
LDQPTQTVVMHRTEP	EIF3CL	836	B5ME19
KSQIHEPENLMPTQI	KDM3A	711	Q9Y4C1
ETSMLLDQVHPPINE	C2CD3	341	Q4AC94
SMVQQHLDDPSLPIN	DOCK1	1506	Q14185
NVMEEPVIITRNSHP	FRS3	111	O43559
IIPLHSLMPTVNQTQ	DHX36	521	Q9H2U1
MQESVQVNGRVPLPH	AXIN1	356	O15169
AMPHTTPIADIQQGI	GARRE1	66	O15063
HAIHVVQQAPTVTMV	FOXK1	511	P85037
PQIATLAQVSMPAAH	CREB1	31	P16220
EVQIFAPDVPQMHVI	GATD3	76	P0DPI2
NHPTMPNTQVVAIPN	FOXM1	66	Q08050
NNPTVQQIVQLSPVM	GOLGA6D	676	P0CG33
LQMITIHLPSPVTAQ	EEF2	351	P13639
QSIHETIPLVSQNIM	AHCTF1	1691	Q8WYP5
LMDQHFTEPTPIQCQ	DDX17	186	Q92841
PQPQTSEHLAAIEIM	EIF2S3B	166	Q2VIR3
PTPHAEQMVSQQRIL	HDAC9	296	Q9UKV0
PVTDTNIPSHLEQML	FHIP2A	46	Q5W0V3
NPVMNSPVVSVAVFH	CELSR3	2436	Q9NYQ7
QAVTTAAQMHQPPLP	GJA3	396	Q9Y6H8
AVHVVSVAVQQFPQM	GRIK2	326	Q13002
PQIIEQAVMIPQNVH	DNAH10	966	Q8IVF4
NQINHLPPLGSTIVM	SBNO1	91	A3KN83
DEIHPMNLAQTPEQS	MAP3K19	781	Q56UN5
THIDVDVNTVKQMPP	C9orf72	306	Q96LT7
AHSINELSQVPPPVM	PIP4K2C	56	Q8TBX8
HMVLQVPQESETIPL	MR1	286	Q95460
VLLNAPVVAMTQGPH	IL4I1	281	Q96RQ9
QHCPILTVIIQPMNE	RP1	1916	P56715
SVTTNTPVPQMQLHT	MROH2A	331	A6NES4
TPVPQMQLHTIFTEL	MROH2A	336	A6NES4
VHTTPLPEEMNLQRV	MROH2A	1276	A6NES4
LQVPNMEVTHVSQLT	PVR	51	P15151
PHNRIMLTTPQQIQL	TAF4	771	O00268
QPRLVVSAMQLHPVQ	RGSL1	1051	A5PLK6
LPTPMAQAEAQAHLQ	SPATA31A6	486	Q5VVP1
VNRSHSVPENMVEPP	PLEKHG3	1076	A1L390
NHTINELSNVPVPVM	PIP4K2B	51	P78356
PVMVPAADILNHLAN	SETD6	241	Q8TBK2
SQLEIHLVNVNMVVP	PKHD1	56	P08F94
ILPNAENSGIMHPIT	PKHD1	3296	P08F94
IVMHNPKVIVQFQPS	SEC23IP	391	Q9Y6Y8
TEGIMVHPNQEPAVI	SRR	146	Q9GZT4
SPAHPQLPVLQTQMV	SRCAP	6	Q6ZRS2
QIPPEDSEIITNMAH	STXBP1	431	P61764
TLEEMPTVQHPFLNV	DUSP26	31	Q9BV47
HIQASVPASSPVMEQ	NCKIPSD	341	Q9NZQ3
HINTDMTLLPEVGNP	SEC24D	951	O94855
VQIPVSAVQLHQMAV	SRF	466	P11831
MAQDSPPQILVHPQD	ROBO4	26	Q8WZ75
IPKSMTPAHIVENIQ	AKR1B15	261	C9JRZ8
AMVQQQLQRSVLHPP	EIF4ENIF1	896	Q9NRA8
NVSTMEPIVLQSVPH	MLLT10	116	P55197
DIVPMGVPHNIIQDT	CYP2G1P	16	Q6ZSU1
DQSQVPRVPTHTLAM	ANKHD1	711	Q8IWZ3
MVPNATIHQDPQSIF	ANKHD1	2146	Q8IWZ3
VAQNSSIMPEPEHVI	CHAT	291	P28329
SNQEANIPLLPHMSI	ROR1	876	Q01973
IHQRHITMPTSVPQQ	SPATA13	611	Q96N96
PQVIVPDSKLIQHMN	GTF2A1	116	P52655
RIQMHVLSQHSVQPV	ZFHX4	1186	Q86UP3
LNSIIEHMPPESVDQ	CSE1L	751	P55060
VPHVANEVQMNVDGP	UTP14C	356	Q5TAP6
EVQVLSQSMPLTPHQ	ZNF250	176	P15622
MPPLLVVQTLAHNST	VPS11	751	Q9H270
MILPVTHTEISPEQQ	TMEM175	51	Q9BSA9
HPTSQNRMIVVTPNR	MIOS	331	Q9NXC5
QFISSIHPEQSVIMP	SPEN	3066	Q96T58
SAIASQLVHAPPMQL	KIF20A	501	O95235
SVVSPQHSHQPPVQM	SH3RF3	646	Q8TEJ3
MHLVARETLPEPNSQ	UBL3	86	O95164
MTSHQPQPQEEQSPQ	SPDYE3	1	A6NKU9
VVEGLVATQPPMHLN	PPM1M	151	Q96MI6
PQLTQMSVPLVHQVK	ZNF592	531	Q92610
NIHNPHSEPLQVVEM	TMEM131	231	Q92545
ITGLVQLVPQSHMPE	NF1	526	P21359
QLVPQSHMPEIAQEA	NF1	531	P21359
GTNIAPDEHVQPQLM	SLU7	146	O95391
TEHIDFATPIQQPAM	TTC17	931	Q96AE7
TPSHQVTQMGQEVIL	TRBV2	26	A0A1B0GX68
QIIQPPPHIQTMSVD	YLPM1	421	P49750
QMGPSQTEPVHVITL	ZBTB24	626	O43167
HVMPSVQLPPNINLV	ZHX2	241	Q9Y6X8
QLPGHQEMPLTFQDV	ZNF251	6	Q9BRH9
QVPPSQVGMLDTLHQ	ZSWIM3	486	Q96MP5
RTSRHMQQQPVVAVP	VPS13B	971	Q7Z7G8
LGPHNQESTVQPMIT	ERVK-18	71	P63123
LSPQHITHQTMPIGQ	ZFP62	96	Q8NB50
VLNMESLPTVHNEGP	ZNF821	201	O75541
MPVPVHVEQIVVNVH	TRAPPC10	616	P48553
VVHPSMDQNDPLVRS	GTF3C1	691	Q12789
IRHPSELMNVPLQQQ	TCFL5	221	Q9UL49
PNPVRNLHMETQTNS	PTPRH	386	Q9HD43
PQRMNVQVTQHRTDP	ZNF638	66	Q14966
GQSVVNLQEMVLHVP	ZFHX3	3491	Q15911
LNHPDVDSPEVTNVM	ZNF518B	946	Q9C0D4
VTVPSGHQQPMQLIF	ZAN	496	Q9Y493
KTVEVPIHQLPASMN	TMPPE	191	Q6ZT21
PQPQTSEHLAAIEIM	EIF2S3	166	P41091